Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy

Lung adenocarcinoma (LUAD) is a devastating disease with poor patient survival. Cancer immunotherapy has revolutionized the treatment of LUAD, but only a limited number of patients effectively respond to this treatment. Thus, the work to elucidate the LUAD immune heterogeneity could be crucial in de...

Full description

Bibliographic Details
Main Authors: Yang Song, Shi Yan, Weina Fan, Mengyan Zhang, Wei Liu, Hailing Lu, Mengru Cao, Chenguang Hao, Lin Chen, Fanglin Tian, Yuning Zhan, Li Cai, Ying Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
lung adenocarcinoma
tumor immune microenvironment
immune subtypes
clinicopathological features
molecular and cellular characteristics
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.00550/full

Similar Items

Similar Items